Patent ID: 6746668
Filing Date: 2004-06-08
Classification: A01K,A61K,A61P,C07K,Y10S

Abstract:
A method of treating a mammal having prostate cancer, comprising administering to the mammal Apo-2 ligand polypeptide in an amount effective to induce cell death in the mammal's prostate cancer cells, wherein said Apo-2 ligand polypeptide is selected from the group consisting of:(a) a polypeptide comprising amino acid residues 114-281 of FIG. 1A (SEQ ID NO:1); (b) a polypeptide consisting of amino acid residues 114-281 of FIG. 1A (SEQ ID NO:1); (c) a polypeptide consisting of amino acid residues 1-281 of FIG. 1A (SEQ ID NO:1); (d) a polypeptide which is a fragment of (a), (b) or (c).